MIRA Pharmaceuticals, Inc. Preferred Shares: Authorized and Outstanding
The company's filed XBRL preferred stock facts (us-gaap Preferred*), one row per period end, newest first. Values are as filed.
- 2026-06-30: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 10.00M shares; Preferred Stock, Shares Issued 0.00 shares.
- 2026-03-31: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, No Par Value $0.00; Preferred Stock, Shares Authorized 10.00M shares; Preferred Stock, Shares Issued 0.00 shares.
- 2025-12-31: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, No Par Value $0.00; Preferred Stock, Shares Authorized 10.00M shares; Preferred Stock, Shares Issued 0.00 shares.
- 2025-09-30: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 10.00M shares; Preferred Stock, Shares Issued 0.00 shares.
| Period end | Preferred Stock, Par or Stated Value Per Share | Preferred Stock, No Par Value | Preferred Stock, Shares Authorized | Preferred Stock, Shares Issued | Preferred Stock, Shares Outstanding | Preferred Stock Dividends, Income Statement Impact |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-12 | 10.00M shares 10-Q · filed 2026-08-12 | 0.00 shares 10-Q · filed 2026-08-12 | 0.00 shares 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | $0.00 10-Q · filed 2026-05-14 | 10.00M shares 10-Q · filed 2026-05-14 | 0.00 shares 10-Q · filed 2026-05-14 | 0.00 shares 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-12 | $0.00 10-Q · filed 2026-05-14 | 10.00M shares 10-Q · filed 2026-08-12 | 0.00 shares 10-Q · filed 2026-08-12 | 0.00 shares 10-Q · filed 2026-08-12 | $21.56M 10-K · filed 2026-03-31 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | 10.00M shares 10-Q · filed 2025-11-13 | 0.00 shares 10-Q · filed 2025-11-13 | 0.00 shares 10-Q · filed 2025-11-13 | $21.56M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | 10.00M shares 10-Q · filed 2025-08-14 | 0.00 shares 10-Q · filed 2025-08-14 | 0.00 shares 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | 10.00M shares 10-Q · filed 2025-05-14 | 0.00 shares 10-Q · filed 2025-05-14 | 0.00 shares 10-Q · filed 2025-05-14 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-03-31 | 10.00M shares 10-K · filed 2026-03-31 | 0.00 shares 10-K · filed 2026-03-31 | 0.00 shares 10-K · filed 2026-03-31 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | 10.00M shares 10-Q · filed 2024-11-12 | 0.00 shares 10-Q · filed 2024-11-12 | 0.00 shares 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | $0.00 10-Q/A · filed 2024-08-16 | 10.00M shares 10-Q/A · filed 2024-08-16 | 0.00 shares 10-Q/A · filed 2024-08-16 | 0.00 shares 10-Q/A · filed 2024-08-16 | ||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-13 | 10.00M shares 10-Q · filed 2024-05-13 | 0.00 shares 10-Q · filed 2024-05-13 | 0.00 shares 10-Q · filed 2024-05-13 | ||
| 2023-12-31 | $0.00 10-K · filed 2025-03-28 | 10.00M shares 10-K · filed 2025-03-28 | 0.00 shares 10-K · filed 2025-03-28 | 0.00 shares 10-K · filed 2025-03-28 | ||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 | 10.00M shares 10-Q · filed 2023-11-13 | 0.00 shares 10-Q · filed 2023-11-13 | 0.00 shares 10-Q · filed 2023-11-13 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-09-15 | 10.00M shares 10-Q · filed 2023-09-15 | 0.00 shares 10-Q · filed 2023-09-15 | 0.00 shares 10-Q · filed 2023-09-15 | ||
| 2022-12-31 | $0.00 10-K · filed 2024-04-01 | 10.00M shares 10-K · filed 2024-04-01 | 0.00 shares 10-K · filed 2024-04-01 | 0.00 shares 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |